Dr. John Thomas Ruffino, MD

Dr. Ruffino practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Ruffino's NPI, 1407122872, was assigned on March 29, 2012. Dr. Ruffino graduated from Weill Cornell Medicine in 2012. Dr. Ruffino holds Texas license Q3954.

Dr. Ruffino's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Ruffino's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Ruffino is also affiliated with Texas Health Dallas. The medical group on file is Texas Health Physicians Group. Dmand AI also links Dr. Ruffino to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ruffino practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ruffino's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ruffino is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Ruffino's licenses on file in 3 states: Texas, Florida and New York.

Dmand AI lists acute diabetes, cardiac arrhythmia, cellulitis, circulation problems, circulatory problems in extremities, congestive heart failure, electrolyte disorders and gastrointestinal bleeding among the conditions Dr. Ruffino treats.

CMS data shows 1,556 Medicare services from Dr. Ruffino across 4 procedure codes in 2024, for 638 Medicare patients. Medicare paid $123,656 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 638 Medicare patients who saw Dr. Ruffino in 2024. The largest group is 75 to 84, with 238 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ruffino's median patient age at 71, with 54% women.

In 2024, Dr. Ruffino wrote 507 Medicare Part D claims for 277 patients. 92% of them were for generic drugs. CMS names the drug for 256 of them, across 14 drugs with 11 or more claims each, at $13,733 in total drug cost. In 2023, CMS named 233 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 53 out of 100 for Dr. Ruffino for performance year 2024, reported individually. Dr. Ruffino accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Ruffino, published from 2011 to 2016. Dr. Ruffino's most frequent co-authors are Parag Goyal, MD, Evelyn Miriam Horn, MD and Mark S. Lachs, MD.

CMS Open Payments shows 16 general payments to Dr. Ruffino from 8 drug and device companies from 2018 to 2021. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $375.

Dr. Ruffino graduated from Weill Cornell Medicine in 2012.

Dr. Ruffino is in network with 19 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.